Cargando…

Risk Prediction Models and Novel Prognostic Factors for Heart Failure with Preserved Ejection Fraction: A Systematic and Comprehensive Review

BACKGROUND: Patients with heart failure with preserved ejection fraction (HFpEF) have large individual differences, unclear risk stratification, and imperfect treatment plans. Risk prediction models are helpful for the dynamic assessment of patients' prognostic risk and early intensive therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shanshan, Yang, Zhihua, Liu, Yangxi, Bi, Yingfei, Liu, Yu, Zhang, Zeyu, Zhang, Xuan, Jia, Zhuangzhuang, Wang, Xianliang, Mao, Jingyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Medicine, Immunology, Inflammation & Allergy, Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614113/ https://www.ncbi.nlm.nih.gov/pubmed/37644795 http://dx.doi.org/10.2174/1381612829666230830105740

Ejemplares similares

Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
por: Fan, Yujian, et al.
Publicado: (2023)

Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Lin, Shanshan, et al.
Publicado: (2021)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension
por: Yang, Zhihua, et al.
Publicado: (2023)

Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis
por: Peng, Ya‐Qi, et al.
Publicado: (2022)

IL‐10 differentially controls the infiltration of inflammatory macrophages and antigen‐presenting cells during inflammation
por: Liao, Chia‐Te, et al.
Publicado: (2016)

Functional and phenotypical analysis of IL‐6‐secreting CD4(+) T cells in human adipose tissue
por: de Jong, Anja J., et al.
Publicado: (2018)

The intestinal microbiota determines the colitis‐inducing potential of T‐bet‐deficient Th cells in mice
por: Zimmermann, Jakob, et al.
Publicado: (2017)

T cells and ILC2s are major effector cells in influenza‐induced exacerbation of allergic airway inflammation in mice
por: Li, Bobby W. S., et al.
Publicado: (2018)

Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation
por: Lv, Jiajia, et al.
Publicado: (2018)

Statins can suppress DC‐mediated Th2 responses through the repression of OX40‐ligand and CCL17 expression
por: Inagaki‐Katashiba, Noriko, et al.
Publicado: (2019)

IL‐31 transgenic mice show reduced allergen‐induced lung inflammation
por: Neuper, Theresa, et al.
Publicado: (2020)

Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects
por: de Graaf, Dennis M., et al.
Publicado: (2020)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

Distinct T cell subsets in adipose tissue are associated with obesity
por: Haugstøyl, Martha E., et al.
Publicado: (2022)

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2021)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

Corrigendum: Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2022)

Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms
por: Yang, Zhihua, et al.
Publicado: (2023)

Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China
por: Tang, Yi, et al.
Publicado: (2022)

Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction
por: Li, Qing, et al.
Publicado: (2022)

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
por: Lu, He, et al.
Publicado: (2023)

Efficacy and Safety of Yangyin Shuxin Decoction—a Chinese Herbal Medicine Formula For Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial
por: Li, Qing, et al.
Publicado: (2022)

Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data
por: Yang, Chunling, et al.
Publicado: (2022)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk
por: Li, Jun-Feng, et al.
Publicado: (2023)

Research based on the core pathogenesis in the treatment according to traditional Chinese medicine syndrome differentiation for heart failure with normal ejection fraction
por: Zhao, Zhiqiang, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study
por: Liu, Xintian, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Network Pharmacology and Molecular Docking Analysis of Shufeiya Recipe in the Treatment of Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Perceptions on HIV Pre-Exposure Prophylaxis Among Urgent Care Clinicians in the Southern United States
por: Burns, Charles M., et al.
Publicado: (2022)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Lin, Yaowang, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Nitidine Chloride Triggers Autophagy and Apoptosis of Ovarian Cancer Cells through Akt/mTOR Signaling Pathway
por: Lian, Chaoqun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fsbklrm0omcp2gk974a95tjsju